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As we previously demonstrated the role of different Kþ channels in the action of nicorandil on human
saphenous vein (HSV) and human internal mammary artery (HIMA), this study aimed to analyse the
contribution of the cGMP pathway in nicorandil-induced vasorelaxation and to determine the involve-
ment of cGMP in the Kþ channel-activating effect of nicorandil. An inhibitor of soluble guanylate cyclase
(GC), ODQ, signiﬁcantly inhibited nicorandil-induced relaxation, while ODQ plus glibenclamide, a se-
lective ATP-sensitive Kþ (KATP) channel inhibitor, produced a further inhibition of both vessels. In HSV,
ODQ in combination with 4-aminopyridine, a blocker of voltage-gated Kþ (KV) channels, did not modify
the concentration-response to nicorandil compared with ODQ, whereas in HIMA, ODQ plus iberiotoxin, a
selective blocker of large-conductance Ca2þ-activated Kþ (BKCa) channels, produced greater inhibition
than ODQ alone. We showed that the cGMP pathway plays a signiﬁcant role in the vasorelaxant effect of
nicorandil on HSV and HIMA. It seems that nicorandil directly opens KATP channels in both vessels and
BKCa channels in HIMA, although it is possible that stimulation of GC contributes to KATP channels
activation in HIMA. Contrary, the activation of KV channels in HSV is probably due to GC activation and
increased levels of cGMP.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Nicorandil (N-[2-hydroxyethyl])-nicotinamide nitrate) is an
antianginal agent with a distinctive dual mechanism of action. The
drug exerts its pharmacodynamic effect through the opening of Kþ
channels and by increasing cyclic guanosine monophosphate
(cGMP) levels by activating guanylate cyclase (GC) via its nitrate (1).
The opening of Kþ channels in vascular smoothmuscle cells leads to
Kþ efﬂux and membrane hyperpolarisation, which inhibits calciumology, Faculty of Pharmacy,
lgrade, Serbia. Tel.: þ381 11
akovic).
rmacological Society.
g by Elsevier B.V. on behalf of Japa
d/4.0/).inﬂux and promotes relaxation (2,3). Cyclic GMP activates the
cGMP-dependent protein kinase (PKG), which initiates phosphor-
ylation events that lead to vascular relaxation (4).
There is some evidence that plasmalemmal Kþ channels play a
signiﬁcant role in PKG-induced vasorelaxation (5). For example,
large-conductance Ca2þ-activated Kþ (BKCa) channels and voltage-
gated Kþ (KV) channels have been found to be activated via the
cGMP pathway in human umbilical (6) and human pulmonary (7)
arteries. The properties of nicorandil as a hybrid compound raise
the possibility that activation of GC and the resulting increase in
cGMP might contribute to Kþ channel activation (8).
Recently, we have demonstrated that different Kþ channel
subtypes are involved in the nicorandil-induced relaxation of hu-
man bypass grafts. In particular, we have shown that: i) nicorandil
endothelium-independently relaxed human saphenous vein (HSV)nese Pharmacological Society. This is an open access article under the CC BY-NC-ND
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used conduit vessels for coronary artery bypass surgery; ii) ATP-
sensitive Kþ (KATP) channels and 4-aminopyridine (4-AP)-sensi-
tive Kþ channels located in the smooth muscle of HSVmediated the
relaxation induced by nicorandil and iii) KATP and BKCa channels are
probably involved in the action of nicorandil on HIMA (9). Until
now, it has not been clear whether the nicorandil-induced activa-
tion of these Kþ channels in HSV and HIMA occurs directly or
dependently of cGMP. Previous studies have demonstrated that the
Kþ channel-dependent effect of nicorandil is independent of cGMP,
acting on the channel (10,11). In contrast, some authors suggested
the possible involvement of cGMP on nicorandil-induced activation
of KATP (8) and BKCa (12) channels. Thus, the principal aim of the
present study was to analyse the contribution of the cGMP pathway
to the nicorandil-induced vasorelaxation of HSV and HIMA and to
determine the role of cGMP as a second messenger in the Kþ
channel-activating effect of nicorandil.2. Materials and methods
2.1. Tissue preparation
Discarded segments of HSV (n ¼ 32) and HIMA (n ¼ 39) were
obtained from 53 male patients (mean age ± S.E.; 63 ± 6 years)
undergoing coronary artery bypass surgery. All patients were
informed in detail about the aims of investigation and gave their
written consent for the excision of remaining tissue. The ex-
periments involving human vessels were approved by the Ethics
Committee of Institute for Cardiovascular Diseases “Dedinje”
and carried out in accordance with the Declaration of Helsinki
and guidelines on Good Clinical Practice. After excision, the
vessel segments were immediately placed in cold (4 C) Krebs-
Ringer-bicarbonate solution, and transported to the laboratory
for study.
Excess fat and connective tissuewere dissected and the HSV and
HIMA segments were cut into 3-mm rings. One to two rings were
obtained from each vessel segment. The endotheliumwas removed
mechanically by gently rubbing the intimal surface with a stainless
steel wire. Denudation of endotheliumwas veriﬁed by the inability
of veins and arteries to relax after treatment with acetylcholine
(1 mM) (13).
The rings were mounted between two stainless-steel triangles
in a 10ml organ bath ﬁlled with Krebs-Ringer-bicarbonate solution,
maintained at 37 C and aerated with 95% O2e5% CO2. The prepa-
rationwas stretched to a resting force of 2 g (14,15) and equilibrated
for 60 min, with frequent washing and force adjustment.2.2. Experimental protocol
After equilibration, HSV and HIMA rings were contracted with
phenylephrine (10 mM). The concentration of phenylephrine was
elected on the basis of previous publications (16,17). When the
contractile response by this vasoconstrictor agent reached a stable
plateau, increasing cumulative concentrations of nicorandil
(0.001 mMe300 mM) were added to the bath. Increasing concen-
trations of nicorandil were added after the relaxation evoked by the
previous concentration reached its plateau or after 20 min if no
response was obtained. To determine the role of the cGMP pathway
in nicorandil-induced relaxation, the rings were treated with (1)
1H-[1,2,4]oxadiazolo[4,3-a]quinoxaline-1-one (ODQ), an inhibitor
of soluble GC, and (2) different Kþ channel blockers for minimum
20 min before the next concentration-response curve to nicorandil
was assessed. Control rings had no blocking drugs added before
titration with nicorandil.2.3. Treatment of data and statistics
The relaxation produced by each concentration of nicorandil
was measured and expressed as a percentage of the maximum
possible relaxation (i.e., relaxation back to the baseline tension).
The concentration of nicorandil producing 50% of the maximum
response (EC50) was calculated from each concen-
trationerelaxation curve using a non-linear least squares ﬁt with a
logistic function and presented as pD2 (pD2 ¼ log EC50).
The results are expressed as themean ± standard deviation (SD).
The value of n indicates the number of experiments. Signiﬁcant
difference between means of different groups was determined by
the unpaired Student's t-test, and a P value <0.05 was considered
statistically signiﬁcant. All calculations were performed using the
computer program Origin (version 8; OriginLab Corporation,
Northampton, MA, USA).
2.4. Drugs
The following drugs were used: nicorandil, phenylephrine hy-
drochloride, acetylcholine iodide, ODQ, glibenclamide, 4-AP and
iberiotoxin (SigmaeAldrich Inc., St. Louis, MO, USA). Nicorandil was
dissolved in distilled water prior to being used. Glibenclamide and
ODQ were dissolved in dimethyl sulfoxide. Previous experiments
established that the solvents used had no effects on the prepara-
tions at the concentrations applied (data not shown). The drugs
were added directly to the bath, and the concentrations given are
the calculated ﬁnal concentrations in the bath solution.
Krebs-Ringer-bicarbonate solution had the following composi-
tion (in mM): 118.3 NaCl, 4.7 KCl, 2.5 CaCl2, 1.2 MgSO4, 25 NaHCO3,
1.2 KH2PO4 and 11.1 glucose; pH 7.4.
3. Results
3.1. Effects of nicorandil on HSV and HIMA without endothelium
pre-contracted by phenylephrine
Nicorandil (0.001 mMe300 mM) induced a concentration-
dependent relaxation of denuded HSV and HIMA rings with pD2
values of 5.87 ± 0.10 (maximal response 100 ± 3%, n ¼ 8) (Fig. 1A)
and 5.60 ± 0.09 (maximal response 100 ± 4%, n ¼ 8) (Fig. 1B),
respectively. The difference between the pD2 values was not sta-
tistically signiﬁcant (P > 0.05).
A time-matched control was used throughout the experiments,
and any observed changes in tensionwere used for the subsequent
adjustment of the drug-induced relaxation. The following method
was used: the percentage relaxation in control conditions was
compared with that in the presence of nicorandil at the same time-
point after phenylephrine application.
3.2. Effects of ODQ and the combination of ODQ and Kþ channel
blockers on the relaxation response of HSV and HIMA to nicorandil
In control rings, to which ODQ or a combination of ODQ plus Kþ
channel blockers were not added, the relaxation induced by nic-
orandil was similar in initial and subsequent concentration-
response curves. No signiﬁcant differences with respect to either
pD2 or maximal response were found between the relaxation
curves.
To examine the role of soluble GC in nicorandil-induced relax-
ation, the effects of ODQ (10 mM), an inhibitor of soluble GC, were
investigated. Pre-incubation with ODQ caused a signiﬁcant inhibi-
tion of the nicorandil-stimulated relaxation of HSV (Table 1 and
Fig.1A) and partially antagonised the nicorandil-induced relaxation
of HIMA (Table 2 and Fig. 1B).
Fig. 1. Relaxant responses to nicorandil in human saphenous vein (HSV) (A) and human internal mammary artery (HIMA) (B) pre-contracted with phenylephrine (10 mM) in the
absence and presence of ODQ and Kþ channel blockers. Concentration-response curves to nicorandil in the absence and presence of ODQ (10 mM) (A, B), ODQ (10 mM) plus gli-
benclamide (GLB, 10 mM) (A, B), ODQ (10 mM) plus 4-aminopyridine (4-AP, 0.5 mM) (A) or ODQ (10 mM) plus iberiotoxin (IbTx, 100 nM) (B). Endotheliumwas removed mechanically
by rubbing with a steel wire. Responses are expressed as a percentage of the maximum possible relaxation, i.e., the return of vessel tension to the pre-phenylephrine level. Each
point represents the mean ± SD (n ¼ 6e8).
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channel-activating effect of nicorandil, we used combinations of
ODQ and Kþ channel blockers (glibenclamide, 4-AP, iberiotoxin)
that had previously been shown to signiﬁcantly inhibit the
nicorandil-induced relaxation of HSV and HIMA (9).
The combination of ODQ plus glibenclamide (10 mM), a selective
KATP channel inhibitor, produced a greater inhibition of nicorandil-
induced relaxation of both HSV (Table 1 and Fig. 1A) and HIMA
(Table 2 and Fig. 1B) than did ODQ alone.
In HSV, pre-incubation with ODQ in combination with 4-AP
(0.5 mM), a widely used blocker of KV channels, did not signiﬁ-
cantly modify the concentration-response to nicorandil compared
with ODQ alone (Table 1 and Fig. 1A).
In HIMA, the combination of ODQ plus iberiotoxin (100 nM), a
selective blocker of BKCa channels, produced inhibition of
nicorandil-induced relaxation, which was signiﬁcantly greater than
that induced by ODQ alone (Table 2 and Fig. 1B).
Glibenclamide (10 mM), ODQ (10 mM) and 4-AP (0.5 mM) had no
apparent effect on the resting tension or the phenylephrine-
induced contraction. The presence of iberiotoxin (100 nM) caused
an increase in resting tension (data not shown). Changes in tension
were recorded, and 100% relaxation was considered when the
tension returned to baseline level (18).
4. Discussion
Nicorandil induces vasodilation via two main mechanisms of
action, activation of Kþ channels, acting as a potassium channelTable 1
Effects of ODQ and combinations of ODQ and Kþ channel blockers on the nicorandil-
induced relaxation of HSV.
n pD2 Emax (%)
Control E 6 5.88 ± 0.19 100 ± 2
ODQ 10 mM 6 nc 29 ± 3**
ODQ 10 mM 7 nc 29 ± 2
ODQ 10 mM þ GLB 10 mM 7 nc 4 ± 1##
ODQ 10 mM 7 nc 28 ± 4
ODQ 10 mM þ 4-AP 0.5 mM 7 nc 18 ± 2
The results are expressed asmean ± SD. n, number of experiments; pD2¼log EC50;
Emax, maximal relaxation; E, without endothelium; GLB, glibenclamide; 4-AP, 4-
aminopyridine; nc, not calculated (because of the low efﬁcacy). ** P < 0.01 vs.
control group, ## P < 0.01 vs. ODQ-treated group.opener, and increasing cGMP levels by stimulation of GC, like a
nitrate (Fig. 2). The relative contribution of each of these vasodilator
mechanisms of action depends on the experimental protocol and
the preparations studied (11). To analyse the involvement of cGMP
in nicorandil-induced relaxation of the isolated, endothelium-
denuded HSV and HIMA grafts, we used ODQ (10 mM), an inhibi-
tor of soluble GC. It has been shown that ODQ inhibits NO-
stimulated soluble GC activity and does not affect the activity of
either particulate GC or adenylate cyclise (19). Since the IC50 value
of ODQ for the NO-stimulated enzyme ranges from 0.2 to 0.7 mM, it
can be expected that ODQ, in concentration of 10 mM, achieves
virtually complete inhibition of NO-stimulated soluble GC (20). Our
results show that the relaxant effect of nicorandil on
phenylephrine-induced contraction of the HSV was signiﬁcantly
inhibited by ODQ (Emax reduced from 100 ± 2% to 29 ± 3%). This
observation is in agreement with results reported by Wang et al.
(21) indicating that activation of the cGMP pathway is an important
mechanism by which nicorandil induced its relaxant effect on HSV.
In HIMA, ODQ produced partial inhibition (Emax reduced from
100 ± 3% to 57 ± 6%) suggesting that the cGMP pathway is, at least
in part, involved in the action of nicorandil on this blood vessel. The
differing nicorandil responses of HSV and HIMA in the presence of
ODQ could be the consequence of the well-documented tissue-
speciﬁc action of nicorandil. Additionally, it is well known that the
vasodilation caused by nitrates is essentially predominant in the
venous circulation (22,23).
As we have previously shown the roles of different Kþ channel
subtypes (KATP, BKCa and 4-AP-sensitive Kþ channels) in the actionTable 2
Effects of ODQ and combinations of ODQ and Kþ channel blockers on the nicorandil-
induced relaxation of HIMA.
n pD2 Emax (%)
Control E 7 5.58 ± 0.18 100 ± 3
ODQ 10 mM 7 4.13 ± 0.17** 57 ± 6**
ODQ 10 mM 7 4.14 ± 0.13 55 ± 3
ODQ 10 mM þ GLB 10 mM 7 nc 13 ± 2##
ODQ 10 mM 8 4.09 ± 0.21 57 ± 4
ODQ 10 mM þ IbTx 100 nM 8 nc 19 ± 3##
The results are expressed asmean ± SD. n, number of experiments; pD2¼log EC50;
Emax, maximal relaxation; E, without endothelium; GLB, glibenclamide; IbTx,
iberiotoxin; nc, not calculated (because of the low efﬁcacy). ** P < 0.01 vs. control
group, ## P < 0.01 vs. ODQ-treated group.
Fig. 2. Mechanism of vasorelaxant effect of nicorandil on human saphenous vein
(HSV) (A) and human internal mammary artery (HIMA) (B). This ﬁgure suggests that
nicorandil exerts its vasorelaxant effect via both mechanisms, i.e., Kþ channel opening
and guanylate cyclase stimulation. Opening of ATP-sensitive Kþ (KATP) channels on
both vessels, as well as large-conductance Ca2þ-activated Kþ (BKCa) channel opening in
HIMA, most likely occurs as a result of direct activation by nicorandil, although there is
a possibility that stimulation of guanylate cyclase contributes to the KATP channels
activation in HIMA. In contrast, activation of voltage-gated Kþ (KV) channels in HSV is
most likely due to guanylate cyclase activation and an increase of cyclic guanosine
monophosphate (cGMP) levels. IbTx, iberiotoxin; GLB, glibenclamide; PKG, cGMP-
dependent protein kinase.
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whether the drug opens these channels directly or in a cGMP-
dependent manner.
KATP channels have several physiological roles and respond to
changes in the cellular metabolic state, as well as to a number of
endogenous vasodilators that act mostly through the stimulation of
cAMP-dependent protein kinase (PKA). Functional modulation of
KATP channels by cGMP, presumably through activation of PKG, was
ﬁrst demonstrated in vascular smoothmuscle cells (24), and later in
pancreatic b-cells (25), neuronal (26) and cardiac (27) cells. To
investigate the involvement of cGMP in the nicorandil-stimulated
activation of KATP channels in HSV and HIMA, we used a combi-
nation of ODQ and glibenclamide (10 mM). Glibenclamide is known
as one of the speciﬁc blockers of KATP channels at concentrations up
to 10 mM, although when used in a high concentration (>30 mM), it
may block some other types of Kþ channels (8,28,29). Earlier
studies with nicorandil demonstrated that KATP channel openingand GC stimulation were independent pathways that induced the
relaxation of isolated vessels (10,11,30). In contrast, Davie et al. (8)
suggested the possible involvement of cGMP in the activation of
KATP channels by nicorandil. We showed that nicorandil is likely to
exert a direct stimulatory action on smooth muscle KATP channels,
as glibenclamide further reduced the relaxation of HSV and HIMA
in the presence of ODQ. Additionally, by comparing the maximal
inhibitory effect (100 e Emax) induced by the combination of ODQ
and glibenclamide in HSV rings (96%), with total effect of blockers
used individually (71% and 36% (9), respectively), we conﬁrmed
that in HSV these two pathways act in parallel. However, the same
comparison made in HIMA (maximal inhibition of nicorandil-
induced relaxation in the presence of ODQ and glibenclamide in
combination with 87% vs. ODQ alone with 43%, and glibenclamide
alone with 71% (9)) may indicate existence of some interaction. It
may imply possible contribution of cGMP pathway in nicorandil-
induced KATP channels activation in HIMA.
On the other hand, since the combination of ODQ and gliben-
clamide was not sufﬁcient to produce complete inhibition of
nicorandil-induced relaxation of HIMA, it may suggest the possible
involvement of some complementary mechanism of action in this
vessel. According to our previous ﬁndings, the complementary
mechanism of action could be the activation of BKCa channels (9). To
verify the possibility that BKCa channels are directly activated by
nicorandil, we used ODQ in combination with iberiotoxin (100 nM)
(31). Iberiotoxin is a selective blocker of BKCa channels which does
not block small-conductance (SKCa) and intermediate-conductance
(IKCa) Ca2þ-activated Kþ channels, nor other types of Kþ channels
(32,33).
It is well known that BKCa channels are primarily activated
either by an elevation of the intracellular Ca2þ concentration
([Ca2þ]i) or by membrane depolarisation (34). In addition, BKCa
channels are regulated by various protein kinases, including PKG
(35). These channels have been found to be a downstream effector
of the soluble GC/cGMP pathway and to modulate the vasodilator
response to both exogenous nitrovasodilators and endogenous
receptor-mediated NO release in various arteries, such as human
coronary (36) and human pulmonary (7) arteries. However, some
authors showed that NO donors could activate BKCa channels
independently of the soluble GC/cGMP pathway (21,37,38), which is
in agreement with the results of the present study. Namely, we
showed that the use of iberiotoxin in addition to ODQ caused a
further reduction in the relaxation of HIMA (total block of nicor-
andil effect was 81%), which seemed additive relative to either
agent alone (blocking effects of iberiotoxin (34%) (9) plus ODQ
(43%)). This result suggests that nicorandil may open BKCa through
a cGMP-independent mechanism, i.e. these two pathways of nic-
orandil action act in parallel. Consistent with these data, in single
smooth muscle cells isolated from the rat mesenteric artery, an
ODQ-insensitive increased activity of BKCa channels has been re-
ported (39).
KV channels are considered the major Kþ channels controlling
resting membrane potential and [Ca2þ]i in vascular smooth muscle
cells (40,41). These channels appear to be activated by a few
intracellular signalling pathways (42). Although there are
numerous data to support a physiological role for PKA activation of
KV channels, data supporting a similar role for PKG are less abun-
dant (43). For example, Sobey and Faraci (44) demonstrated that
the dilatation of basilar arteries by sodium nitroprusside and 8-
bromo cGMP was selectively inhibited by 4-AP, suggesting the
participation of Kv channel activation in these cGMP-dependent
responses.
Previously, we showed that 4-AP-sensitive Kþ channels are
involved in the nicorandil-induced relaxation of HSV (9). To further
investigate the mechanism by which nicorandil activates KV
M. Marinko et al. / Journal of Pharmacological Sciences 128 (2015) 59e64 63channels, we tested the effects of nicorandil in the presence of 4-AP
(0.5 mM) plus ODQ. 4-AP, in concentration of 0.5 mM (45), is able to
block KV channels, but has no effect on BKCa or inward rectiﬁer Kþ
(Kir) channels (32), nor does it affect the function of KATP channels
(46). By comparing the effects of ODQ and a combination of ODQ
and 4-AP on nicorandil-induced relaxation, it appears that the
maximal inhibition is similar. Further, attenuation of relaxation
made by ODQ and 4-AP when used in combination (82%) is less
than additive attenuation made by both agents when used alone
(71% and 57% (9), respectively). These results indicate existence of
interaction between these pathways, suggesting that nicorandil
probably activates KV channels via a cGMP-dependent signalling
mechanism. This is consistent with results previously obtained on
human umbilical (6), pulmonary (7) and basilar (44) arteries.
KV channels represent a diverse family, of which the KV1
(Shaker-related) family is the most prominently expressed in the
vasculature (47). Similar to BKCa, KV channels are heteromultimeric
proteins composed of transmembrane pore-forming a and cyto-
solic b subunits. Analysis of the protein sequence of KV channels
known to be present in vascular smooth muscle cells indicates that
the KV1.5 and the KVb1 subfamily have consensus PKG phosphor-
ylation sites that may be responsible for the activation of KV
channels by this kinase (43). In HSV, the expression of KV1.3 and
KV1.5 channels was demonstrated (48,49). However, we have pre-
viously shown that margatoxin, a selective inhibitor of KV1.3
channels, did not modify nicorandil-induced relaxation of HSV (9).
This result raised the possibility that the activation of KV1.5 through
a cGMP-dependent pathway is at least partially involved in the
relaxation of HSV induced by nicorandil.
In conclusion, we have demonstrated that the cGMP pathway
plays a signiﬁcant role in the vasorelaxant effect of nicorandil on
HSV and HIMA. Furthermore, it seems that nicorandil directly
opens KATP channels in both vessels and BKCa channels in HIMA,
although there is a possibility that stimulation of GC contributes to
the KATP channels activation in HIMA. In contrast, the activation of
KV channels in HSV is most likely due to the activation of soluble GC
and an increase in cGMP levels.
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